Data / Medical devices / United States / Instrumentation Laboratory Co.
Instrumentation Laboratory Co.: FDA-registered device maker in Orangeburg, NY, United States, 65 510(k) clearances
Instrumentation Laboratory Co. is registered with the FDA (registration 2431530) in Orangeburg, NY, United States. It lists 44 device types. The FDA files 65 510(k) clearances under its listings, the newest dated July 24, 2025. Registered through 2026. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 2431530
- Address
- 526 Route 303, Orangeburg, NY, United States, 10962
- Owner or operator
- Instrumentation Laboratory Co. (1217183)
- Roles
- Manufacturer, Manufacturer for export, Repackager or relabeler, Specification developer
- First device listed
- October 11, 2007
- Registered through
- 2026
- Brand names listed
- ACL TOP 970 CL, Avox-4 Co-Oximeter Control, Avox-4 Co-Oximeter Control - L1, Avox-4 Co-Oximeter Control - L2, Avox-4 Co-Oximeter Control - L3, COATEST SP FVIII, COATEST SP4 FVIII, Calibration Plasma LMW Heparin and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| July 24, 2025 | K251968 | HemosIL Fibrinogen-C; HemosIL Fibrinogen-C XL | KQJ | Substantially Equivalent | Instrumentation Laboratory (IL) Co. | accessdata.fda.gov |
| December 13, 2023 | K230852 | HemosIL Chromogenic Factor IX | GGP | Substantially Equivalent | Instrumentation Laboratory Company | accessdata.fda.gov |
| August 10, 2023 | K223608 | GEM Premier 7000 with IQM3 | CHL | Substantially Equivalent | Instrumentation Laboratory Company | accessdata.fda.gov |
| June 23, 2023 | K223187 | HemosIL Liquid Anti-Xa | QLU | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| January 27, 2023 | K223090 | GEM Premier ChemSTAT | CGA | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| December 9, 2022 | K223402 | HemosIL von Willebrand Factor Antigen | GGP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| October 4, 2022 | K213464 | HemosIL Liquid Anti-Xa | KFF | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| August 16, 2022 | K213426 | HemosIL ReadiPlasTin | GJS | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| August 20, 2021 | K203790 | GEM Premier 5000 | CHL | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| September 17, 2020 | DEN190032 | HemosIL Liquid Anti-Xa | QLU | Unknown | Instrumentation Laboratory CO | accessdata.fda.gov |
| March 22, 2018 | K180486 | HemosIL Factor XII Deficient Plasma | GJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| December 14, 2016 | K160225 | GEM Premier 5000 (Measured Parameters:Sodium, Potassium, Chloride, Ionized Calcium), GEM CVP 5 tBili, GEM System Evaluator, GEM Hematocrit Evaluator | JGS | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| March 16, 2016 | K160445 | HemosIL Silica Clotting Time | GFO | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| January 22, 2014 | K132722 | HEMOSIL RECOMBIPLASTIN 2G (8 ML VIAL) | GJS | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| January 13, 2014 | K133407 | GEM PREMIER 4000 | CHL | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| March 24, 2013 | K122584 | HEMOSIL READIPLAS TIN | GJS | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| May 3, 2012 | K112995 | GEM PREMIER 4000 | CEM | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| January 4, 2012 | K113211 | HEMOSIL LA POSITIVE CONTROL & HEMOSIL LA NEGATIVE CONTROL | GGN | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| August 24, 2011 | K110031 | HEMOSIL DRVVT SCREEN & HEMOSIL DRVVT CONFIRM | GIR | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| July 8, 2011 | K110237 | HEMOSIL FACTOR VIII DEFICIENT PLASMA | GJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| March 17, 2011 | K102164 | HEMOSIL PROTEIN S ACTIVITY ASSAY | GGP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| May 4, 2010 | K093737 | HEMOSIL F11 & FV DNA CONTROL | NZB | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| October 9, 2009 | K090563 | HEMOSIL INR VALIDATE, HEMOSIL ISI CALIBRATE, ISIWEB (SOFTWARE) | GGN | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| June 2, 2009 | K090209 | HEMOSIL LIQUID HEPARIN, HEPARIN CALIBRATORS AND LMW AND UF HEPARIN CONTROLS | KFF | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| December 19, 2008 | K082859 | HEMOSIL ROUTINE CONTROL LEVEL 1, LEVEL 2, LEVEL 3 UNASSAYED | GGN | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| December 27, 2007 | K073367 | HEMOSIL FIBRINOGEN-C | KQJ | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| August 15, 2007 | K070005 | HEMOSIL RECOMBIPLASTIN 2G | GJS | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| March 29, 2007 | K070635 | HEMOSIL PROCLOT | GGP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| February 23, 2007 | K070301 | HEMOSIL ANTITHROMBIN | JBQ | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| September 1, 2006 | K062431 | HEMOSIL LIQUID ANTITHROMBIN | JBQ | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| September 1, 2006 | K062430 | HEMOSIL PROTEIN C | GGP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| May 2, 2006 | K060931 | HEMOSIL PT-FIBRINOGEN HS PLUS | GJS | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| April 13, 2006 | K060688 | HEMOSIL SYNTHASIL | GFO | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| May 2, 2005 | K050661 | HEMOSIL FACTOR II DEFICIENT PLASMA | GJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| February 9, 2005 | K043459 | HEMOSIL FACTOR XII DEFICIENT PLASMA | GJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| December 2, 2004 | K042576 | COATEST SP FVIII | GGP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| September 28, 2004 | K041905 | HEMOSIL CALIBRATION PLASMA | JIX | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| March 19, 2004 | K040359 | HEMOSIL SPECIAL TEST CONTROLS LEVEL 1 & 2 | JPA | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| February 13, 2004 | K034007 | HEMOSIL FACTOR VIII DEFICIENT PLASMA | GJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| July 31, 2003 | K031829 | HEMOSIL FACTOR IX DEFICIENT PLASMA | GJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| June 6, 2003 | K030965 | CONTROL PLASMA LMW HEPARIN | GGN | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| June 6, 2003 | K030964 | CALIBRATION PLASMA LMW HEPARIN | JIS | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| May 19, 2003 | K031122 | HEMOSIL FACTOR X DEFICIENT PLASMA | GJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| March 19, 2003 | K030287 | HEMOSIL FACTOR XI DEFICIENT PLASMA | GJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| February 12, 2003 | K024082 | HEMOSIL FACTOR VII DEFICIENT PLASMA | GJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| January 14, 2003 | K023839 | HEMOSIL FACTOR V DEFICIENT PLASMA | GJT | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| May 16, 2002 | K021024 | HEMOSIL HIGH ABNORMAL CONTROL ASSAYED | GGN | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| May 14, 2002 | K021023 | HEMOSIL NORMAL CONTROL (ASSAYED); HEMOSIL NORMAL CONTROL 1 (UNASSAYED) | GGN | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| May 14, 2002 | K021022 | HEMOSIL LOW ABNORMAL CONTROLLED (ASSAYED); HEMOSIL LOW ABNORMAL CONTROL 2 (UNASSAYED) | GGN | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| May 7, 2001 | K010520 | GEM PREMIER 3000- ADDITION OF GLUCOSE AND LACTATE AS NEW PARAMETERS | CGA | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| November 24, 1999 | K992834 | GEM PREMIER 3000 | CHL | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| November 3, 1998 | K983178 | COAMATIC HEPARIN | KFF | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| August 27, 1998 | K981696 | IL TEST PLASMIN INHIBITOR | GGP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| May 26, 1998 | K981200 | IL TEST PLASMINOGEN | GGP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| April 16, 1998 | K981038 | COAMATIC FACTOR VIII | GGP | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| March 19, 1998 | K980242 | IL TEST HEPARIN | KFF | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| November 4, 1997 | K973306 | IL TEST APTT-SP | GFO | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| December 23, 1996 | K963111 | COATEST APC (TM) RESISTANCE V/COATEST APC (TM) RESISTANCE V S | GGW | Substantially Equivalent | Chromogenix AB | accessdata.fda.gov |
| November 29, 1996 | K963902 | QUANTITATIVE FIBRINOGEN ASSAY | GIS | Substantially Equivalent | Ortho Diagnostic Systems, Inc. | accessdata.fda.gov |
| April 23, 1996 | K955638 | SYNTHAFAX APTT REAGENT | GFO | Substantially Equivalent | Ortho Diagnostic Systems, Inc. | accessdata.fda.gov |
| August 7, 1995 | K945940 | COATEST(R) APC(TM) RESISTANCE | GGW | Substantially Equivalent | Axis-Shield Doc AS | accessdata.fda.gov |
| August 13, 1993 | K931721 | IL TEST FIBRINOGEN-C | KQJ | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| December 7, 1992 | K922201 | COAMATE PROTEIN C CHROMOGENIC ASSAY | GGP | Substantially Equivalent | Chromogenix AB | accessdata.fda.gov |
| September 3, 1986 | K862301 | IL SYSTEM 810, ACL AND THE REAGENT SETS | GJA | Substantially Equivalent | Instrumentation Laboratory CO | accessdata.fda.gov |
| January 30, 1984 | K833891 | COATEST HEPARIN | KFF | Substantially Equivalent | Kabivitrum, Inc. | accessdata.fda.gov |
Compare with other makers
- All makers of Plasma, Coagulation Control
- All makers of Plasma, Coagulation Factor Deficient
- All makers of Test, Qualitative And Quantitative Factor Deficiency
- All makers of Control, Plasma, Abnormal
- All makers of Reagent, Russel Viper Venom
- All makers of Assay, Heparin
Updated July 24, 2025. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.